Researchers presented an exploratory analysis comparing OCT biomarkers in a Phase 1b study of ONL1204 in patients with ...

The Food and Drug Administration has granted Fast Track designation to urcosimod for the treatment of neuropathic corneal pain.

More than 75,000 cases comprising more than 1.8 million cartons of consumer level dry eye drops have been voluntarily recalled.

Investigators developed a novel severity scoring system for age-related macular degeneration that can generate distinct scores for exudative and nonexudative AMD.

The Trump administration has canceled more than $800 million in research focused on LGBTQ health, cutting hundreds of studies on cancer, HIV and other diseases that affect sexual and gender minority ...

Reproxalap ophthalmic solution 0.25% reached the primary endpoint in a second phase 3 dry eye chamber trial, according to Aldeyra Therapeutics.